CD79A and osteosarcoma: Previous studies have demonstrated that CCL2 promotes the proliferation and metastasis of osteosarcoma cells by activating the receptor activator of NF-κB ligand signaling pathway.19,20 CD79a is expressed exclusively on B cells.